Xilio Therapeutics Inc. (XLO)
XLO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$9.22
+1.60% on the day
Market cap
$60.7M
Micro cap
Revenue · 2025
$43.8M
+589.9% on 2024
Net income · 2025
-$35.0M
-80.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | XLO on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001840233 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $43.8M |
| Net income | -$35.0M |
| Operating income | -$42.0M |
| Net margin | -80.1% |
| Operating margin | -95.9% |
| Revenue growth | +589.9% |
| Cash | $137.5M |
| Total assets | $154.7M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-05-12 |
| Latest annual report | 10-K | 2026-03-23 |
| Latest quarterly / interim | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2026-08-12 |
| Latest proxy | DEF 14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 357 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PLRX | Pliant Therapeutics Inc. | $0.9680 | -1.83% | $59.9M |
| TENX | Tenax Therapeutics Inc. | $1.60 | -12.57% | $59.9M |
| VRCA | Verrica Pharmaceuticals Inc. | $3.58 | -10.72% | $61.5M |
| GANX | Gain Therapeutics Inc. | $1.41 | -10.19% | $61.5M |
| GOSS | Gossamer Bio Inc. | $9.76 | +5.17% | $59.7M |
| APLM | Apollomics Inc. | $21.32 | 0.00% | $61.7M |
| CNTB | Connect Biopharma Holdings Limited | $0.9188 | +1.45% | $57.9M |
| ONCY | Oncolytics Biotech Inc. | $0.4900 | +3.53% | $64.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier